Advanced glycation end products contribute to amyloidosis in Alzheimer disease.

Alzheimer disease (AD) is characterized by deposits of an aggregated 42-amino-acid beta-amyloid peptide (beta AP) in the brain and cerebrovasculature. After a concentration-dependent lag period during in vitro incubations, soluble preparations of synthetic beta AP slowly form fibrillar aggregates th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Vitek, M P, Bhattacharya, K, Glendening, J M, Stopa, E, Vlassara, H, Bucala, R, Manogue, K, Cerami, A
Format: Artigo
Jezik:Inglês
Izdano: 1994
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC43869/
https://ncbi.nlm.nih.gov/pubmed/8197133
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki